Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
11 2023
Historique:
received: 14 06 2023
accepted: 18 08 2023
revised: 10 08 2023
medline: 16 11 2023
pubmed: 10 9 2023
entrez: 9 9 2023
Statut: ppublish

Résumé

Fumarate hydratase (FH) is an enzyme of the Tricarboxylic Acid (TCA) cycle whose mutations lead to hereditary and sporadic forms of cancer. Although more than twenty years have passed since its discovery as the leading cause of the cancer syndrome Hereditary leiomyomatosis and Renal Cell Carcinoma (HLRCC), it is still unclear how the loss of FH causes cancer in a tissue-specific manner and with such aggressive behaviour. It has been shown that FH loss, via the accumulation of FH substrate fumarate, activates a series of oncogenic cascades whose contribution to transformation is still under investigation. In this review, we will summarise these recent findings in an integrated fashion and put forward the case that understanding the biology of FH and how its mutations promote transformation will be vital to establish novel paradigms of oncometabolism.

Identifiants

pubmed: 37689804
doi: 10.1038/s41416-023-02412-w
pii: 10.1038/s41416-023-02412-w
pmc: PMC10645937
doi:

Substances chimiques

Fumarate Hydratase EC 4.2.1.2

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1546-1557

Subventions

Organisme : Cancer Research UK
ID : C51061/A27453
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Int J Nephrol Renovasc Dis. 2014 Jun 20;7:253-60
pubmed: 25018647
Sci Signal. 2021 Jan 05;14(664):
pubmed: 33402335
Nat Chem Biol. 2022 Sep;18(9):954-962
pubmed: 35710616
Nat Rev Cancer. 2018 Feb;18(2):128-134
pubmed: 29326430
Nat Rev Cancer. 2003 Oct;3(10):721-32
pubmed: 13130303
J Biol Chem. 2002 Aug 23;277(34):30409-12
pubmed: 12087111
J Urol. 2007 Jun;177(6):2074-9; discussion 2079-80
pubmed: 17509289
Cell. 2017 Jun 1;169(6):1000-1011
pubmed: 28575665
J Exp Med. 2017 Mar 6;214(3):719-735
pubmed: 28202494
Int J Cancer. 2012 Jun 1;130(11):2599-606
pubmed: 21796619
J Clin Endocrinol Metab. 2014 Oct;99(10):E2046-50
pubmed: 25004247
Science. 2000 Feb 4;287(5454):848-51
pubmed: 10657297
Mol Cell Biol. 2012 Aug;32(15):3081-94
pubmed: 22645311
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nat Rev Cancer. 2018 Mar;18(3):148-167
pubmed: 29348577
Cell Rep. 2013 Mar 28;3(3):689-700
pubmed: 23499446
Nature. 2014 Nov 20;515(7527):431-435
pubmed: 25383517
J Pathol. 2011 Sep;225(1):4-11
pubmed: 21630274
Front Oncol. 2022 Jul 15;12:906014
pubmed: 35912170
Biochim Biophys Acta. 1997 Aug 22;1361(2):185-97
pubmed: 9300800
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
N Engl J Med. 2016 Jan 14;374(2):135-45
pubmed: 26536169
Cancer Cell. 2007 Apr;11(4):311-9
pubmed: 17418408
Nature. 2011 Nov 20;481(7381):380-4
pubmed: 22101433
BMC Genomics. 2014 Feb 25;15:158
pubmed: 24568598
Trends Cell Biol. 2021 Jan;31(1):24-36
pubmed: 33092942
Nat Rev Cancer. 2018 Dec;18(12):744-757
pubmed: 30425336
Oncotarget. 2015 Nov 17;6(36):38777-88
pubmed: 26472283
Mol Cancer. 2019 Feb 19;18(1):26
pubmed: 30782187
Aging (Albany NY). 2019 Jan 21;11(2):573-589
pubmed: 30668541
Semin Cell Dev Biol. 2020 Feb;98:15-25
pubmed: 31085323
Biomolecules. 2020 Jan 16;10(1):
pubmed: 31963199
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Cancer Res. 2018 Dec 1;78(23):6539-6548
pubmed: 30297534
Br J Pharmacol. 2015 Jun;172(11):2705-15
pubmed: 25134627
J Cell Sci. 2016 Sep 15;129(18):3367-73
pubmed: 27635066
Cold Spring Harb Perspect Med. 2015 Apr 01;5(4):
pubmed: 25833940
Biomol Concepts. 2014 Jun;5(3):209-24
pubmed: 25372754
Oncogene. 2021 May;40(19):3351-3363
pubmed: 33864000
Structure. 2000 Feb 15;8(2):163-74
pubmed: 10673438
Cancer Cell. 2011 Sep 13;20(3):315-27
pubmed: 21907923
N Engl J Med. 2015 Dec 10;373(24):2336-2346
pubmed: 26580448
Cell Rep. 2017 May 9;19(6):1083-1090
pubmed: 28494858
Cancer Cell. 2011 Oct 18;20(4):524-37
pubmed: 22014577
Science. 2021 Dec 03;374(6572):1227-1237
pubmed: 34855504
Cancer Metab. 2013 Mar 21;1(1):12
pubmed: 24280230
Cancer Res. 2016 Oct 1;76(19):5743-5755
pubmed: 27302170
Trends Cancer. 2022 Dec;8(12):1046-1059
pubmed: 36041967
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Nature. 2020 Aug;584(7819):136-141
pubmed: 32581363
Cell Rep. 2023 Jul 25;42(7):112751
pubmed: 37405921
J Cell Biol. 2018 Jul 2;217(7):2247-2259
pubmed: 29760106
Hum Mol Genet. 2014 May 1;23(9):2440-6
pubmed: 24334767
Genes Dev. 2012 Jun 15;26(12):1326-38
pubmed: 22677546
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):723-731
pubmed: 27956047
Metab Eng. 2018 Jan;45:149-157
pubmed: 29191787
Nature. 2023 Mar;615(7952):499-506
pubmed: 36890229
WIREs Mech Dis. 2023 May-Jun;15(3):e1595
pubmed: 36597256
J Mol Med (Berl). 2011 Mar;89(3):213-20
pubmed: 21301796
Nature. 2016 Aug 31;537(7621):544-547
pubmed: 27580029
Mol Cancer Ther. 2009 Mar;8(3):626-35
pubmed: 19276158
Cell Metab. 2006 Mar;3(3):187-97
pubmed: 16517406
Cell Rep. 2013 May 30;3(5):1440-8
pubmed: 23643539
Urol Int. 2013;90(2):233-9
pubmed: 23295344
PLoS Biol. 2010 Mar 09;8(3):e1000328
pubmed: 20231875
J Clin Invest. 2003 Mar;111(6):779-83
pubmed: 12639980
Genome Med. 2023 May 2;15(1):31
pubmed: 37131267
Sci Adv. 2022 Oct 21;8(42):eabq8297
pubmed: 36269833
J Pathol. 2005 Jan;205(1):41-9
pubmed: 15586379
Mol Med. 1997 Jan;3(1):5-20
pubmed: 9132280
Traffic. 2016 Jul;17(7):720-32
pubmed: 27037871
Cancer Cell. 2014 Dec 8;26(6):840-850
pubmed: 25490448
J Clin Invest. 2023 Jun 1;133(11):
pubmed: 37053010
Genes Dev. 2016 Apr 1;30(7):733-50
pubmed: 27036965
Cell Rep. 2018 Jul 31;24(5):1093-1104.e6
pubmed: 30067967
Cancers (Basel). 2022 Nov 09;14(22):
pubmed: 36428601
Cancer Cell. 2005 Aug;8(2):143-53
pubmed: 16098467
Nature. 2011 Nov 20;481(7381):385-8
pubmed: 22101431
Nature. 2019 Nov;575(7782):380-384
pubmed: 31666695
Nat Rev Cancer. 2018 Oct;18(10):634-645
pubmed: 30194362
Sci Am. 1996 Sep;275(3):62-70
pubmed: 8701295
Mol Cell Biol. 1994 Jul;14(7):4770-8
pubmed: 8007976
J Cancer. 2020 Mar 26;11(12):3596-3603
pubmed: 32284756
Elife. 2021 Mar 01;10:
pubmed: 33646118
PLoS One. 2013 Aug 15;8(8):e72179
pubmed: 23967283
Front Endocrinol (Lausanne). 2022 Oct 13;13:1024423
pubmed: 36313756
Cancer Genet Cytogenet. 2010 Jan 1;196(1):45-55
pubmed: 19963135
Elife. 2021 Dec 23;10:
pubmed: 34939929
Front Oncol. 2021 May 25;11:686556
pubmed: 34113573
Nat Genet. 2002 Apr;30(4):406-10
pubmed: 11865300
Nat Commun. 2015 Jan 23;6:6001
pubmed: 25613188
Life Sci. 2020 Jan 15;241:117140
pubmed: 31812670
Signal Transduct Target Ther. 2021 Jul 12;6(1):263
pubmed: 34248142
Int J Biochem Cell Biol. 2021 Oct;139:106059
pubmed: 34400318
Nat Cell Biol. 2015 Sep;17(9):1158-68
pubmed: 26237645
Nat Chem Biol. 2019 Apr;15(4):391-400
pubmed: 30718813
Semin Cancer Biol. 2022 Oct;85:52-68
pubmed: 33862221
Cell Metab. 2014 Dec 2;20(6):953-66
pubmed: 25456737
Cell Metab. 2006 Mar;3(3):177-85
pubmed: 16517405
Trends Endocrinol Metab. 2017 Oct;28(10):748-757
pubmed: 28938972
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Arch Biochem Biophys. 2006 Jun 1;450(1):1-8
pubmed: 16624247
Nature. 2011 Aug 17;477(7363):225-8
pubmed: 21849978
Free Radic Biol Med. 2016 Nov;100:175-181
pubmed: 27117029
Mol Cell. 2022 Apr 7;82(7):1249-1260.e7
pubmed: 35216667
Cancer Cell. 2019 May 13;35(5):714-720
pubmed: 31085174
Cell Rep. 2017 Oct 24;21(4):1036-1047
pubmed: 29069586
Nat Rev Mol Cell Biol. 2021 Jan;22(1):22-38
pubmed: 33188273
Hum Genome Var. 2022 Jan 17;9(1):3
pubmed: 35034951
Cell Death Dis. 2018 Sep 6;9(9):913
pubmed: 30190474
Sci Rep. 2019 Dec 5;9(1):18409
pubmed: 31804603
Expert Opin Ther Targets. 2020 Sep;24(9):923-936
pubmed: 32744123
Nature. 2023 Mar;615(7952):490-498
pubmed: 36890227
Nat Biotechnol. 2013 Jun;31(6):522-9
pubmed: 23604282
Clin Cancer Res. 2021 Mar 15;27(6):1734-1743
pubmed: 33414138
Cancer Discov. 2023 Sep 6;13(9):2072-2089
pubmed: 37255402
Ann N Y Acad Sci. 2008 Apr;1126:272-5
pubmed: 18448829
Sci Transl Med. 2019 Mar 20;11(484):
pubmed: 30894502
Nat Genet. 2018 Aug;50(8):1086-1092
pubmed: 30013182
Cell Metab. 2023 Jun 6;35(6):961-978.e10
pubmed: 37178684
Hum Mol Genet. 2010 Oct 1;19(19):3844-51
pubmed: 20660115

Auteurs

Lorea Valcarcel-Jimenez (L)

Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, UPV/EHU, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain. lorea.valcarcel@ehu.eus.

Christian Frezza (C)

University of Cologne, Faculty of Mathematics and Natural Sciences, Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany. christian.frezza@uni-koeln.de.
University of Cologne, Faculty of Medicine and University Hospital Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany. christian.frezza@uni-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH